Latest Breaking News On - Chad robins - Page 7 : vimarsana.com

Adaptive Biotechnologies inks royalty deal with healthcare fund to beef up balance sheet

Adaptive Biotechnologies inks royalty deal with healthcare fund to beef up balance sheet
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Charlotte schubertMatthew rizzoHarlan robinsFred hutchinson cancer centerCo founders harlanChad robinsGeekwire photoDiffuse largeb cell lymphomaChief scientific officer harlanAdaptive biotechnologiesGeneral partner

Adaptive Biotechnologies Corporation (ADPT) Q2 2022 Earnings Call Transcript

ADPT earnings call for the period ending June 30, 2022.

David westenberg piper sandlerDavid westenbergElizabeth webster goldman sachsDan brennanKarina calzadillaYuko oku morgan stanleySalveen richterAmerica merrill lynchJulia qinHarlan robinsDan brennan cowenPiper sandlerMark massaroBrian weinstein william blairBrian weinsteinSharon benzeno

Adaptive Biotechnologies Corporation (ADPT) Q1 2022 Earnings Call Transcript

ADPT earnings call for the period ending March 31, 2022.

San franciscoUnited statesAmerica merrill lynchHarlan robinsMark massaroKyle piskelBrian weinstein william blairElizabeth webster goldman sachsSharon benzenoBrian weinsteinKarina calzadillaYuko oku morgan stanleySalveen richterWilliam blairDerik de bruin bankMorgan stanley

Adaptive Biotechnologies reports $38 6M in Q1 revenue as it repositions following job cuts

Adaptive Biotechnologies reports $38 6M in Q1 revenue as it repositions following job cuts
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Kevin lisotaJp morgan chaseHealth techJanssen pharmaceutical companiesAdaptive biotechnologies co founderGeekwire photoTycho petersonChad robins

Adaptive Biotech: Becoming The Next Big Thing In The Biotech Industry (NASDAQ:ADPT)

Adaptive Biotech product 'clonoSEQ' is the first MRD test cleared by FDA for multiple myeloma, CLL, and B-ALL. See why investors should consider adding ADPT stock to their portfolio.

United statesLeslie triggNational comprehensive cancer centerAdaptive biotechnologies corporationDrug administrationT cells workFight cancerAdaptive biotechnologiesAdaptive biotechVolume chartComprehensive cancer centerEmergency use authorizationKatey owenChad robinsAdaptive biotechnologieNavidea biopharmaceutical